#PiperacillinTazobactam
LightNews LightNews
contagionlive.bsky.social
Data from the PETERPEN trial suggest that piperacillin-tazobactam may be noninferior to meropenem in select patients with ESBL bloodstream infections, but carbapenems remain the standard of care until final mortality results are available. #IDsky

www.contagionlive.com/view/carbape...
Carbapenem-Sparing Therapy for ESBL Bacteremia: New Trials, Old Questions | Contagion Live
New data from the PETERPEN trial suggest that piperacillintazobactam may be noninferior to meropenem for early clinical outcomes in select patients with ESBL bloodstream infections, but carbapenems re...
www.contagionlive.com
September 24, 2026 at 8:28 PM
infdiseasesnow.bsky.social
[Publication] The article "Appropriateness of piperacillin-tazobactam prescriptions: a prospective multicentre study" is now available.

www.sciencedirect.com/science/arti...

#IDsky #PiperacillinTazobactam #Audit #DiagnosticUncertainty #AntimicrobialStewardship #AntibioticReassessment
Appropriateness of piperacillin-tazobactam prescriptions: a prospective multicentre study
Our aim was to determine the reasons for appropriate Piperacillin-tazobactam (Pip-Taz) prescriptions.This was a prospective multicentre study of two-m…
www.sciencedirect.com
May 28, 2025 at 7:45 AM